HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mukherjee, S. Articles by Campos-Neto, A. Search for Related Content PubMed PubMed Citation Articles by Mukherjee, S. Articles by Campos-Neto, A.

Cloning of the Gene Encoding a Protective Mycobacterium tuberculosis Secreted Protein Detected In Vivo during the Initial Phases of the Infectious Process¹

Sandeep Mukherjee^2,*, Suely S. Kashino^2,, Yanni Zhang, Nada Daifalla^*, Virmondes Rodrigues, Jr, Steven G. Reed^*,¶ and Antonio Campos-Neto^3,

^* Infectious Disease Research Institute, Seattle, WA 98104; The Forsyth Institute, Boston, MA 02115; Department of Process Science, Corixa Corporation, Seattle, WA 98101; Medical School of Tringulo Mineiro, Uberaba, Minas Gerais, Brazil; and ^¶ Department of Pathobiology, University of Washington, Seattle, WA 98195

The existence of therapeutic agents and the bacille Calmette-Guérin (BCG) vaccine have not significantly affected the current tuberculosis pandemic. BCG vaccine protects against serious pediatric forms of tuberculosis but not against adult pulmonary tuberculosis, the most common and contagious form of the disease. Several vaccine candidates, including Mycobacterium tuberculosis recombinant proteins formulated in newer adjuvants or delivered in bacterial plasmid DNA have recently been described. An attractive source of vaccine candidates has been M. tuberculosis Ags present in culture supernatants of the initial phases of the bacterial growth in vitro. In this study we describe an Ag discovery approach to select for such Ags produced in vivo during the initial phases of the infection. We combined RP-HPLC and mass spectrometry to identify secreted or shed M. tuberculosis proteins eliminated in animal urine within 14 days after the infection. A peptide containing sequence homology with a hypothetical M. tuberculosis protein was identified and the recombinant protein produced in Escherichia coli. The protein was recognized by Ab (IgG2a and IgG1) and T cells (Th1) of mice infected with M. tuberculosis and by lymphoid cells from healthy donors who had a positive purified protein derivative skin test but not from tuberculosis patients. Moreover, this Ag induced protection in mice against M. tuberculosis at levels comparable to protection induced by BCG vaccine. These results validate the Ag discovery approach of M. tuberculosis proteins secreted or shed in vivo during the early phases of the infection and open new possibilities for the development of potential vaccine candidates or of markers of active mycobacterial multiplication and therefore active disease.

This article has been cited by other articles:

				D. R. Napolitano, N. Pollock, S. S. Kashino, V. Rodrigues Jr., and A. Campos-Neto Identification of Mycobacterium tuberculosis Ornithine Carboamyltransferase in Urine as a Possible Molecular Marker of Active Pulmonary Tuberculosis Clin. Vaccine Immunol., April 1, 2008; 15(4): 638 - 643. [Abstract] [Full Text] [PDF]